Funds holding Eikon Therapeutics Inc
ISIN US2825641036 · United States
- Fund holders
- 37
- Of which ETFs
- 2 35 other funds
- Value held
- 87.6M $
- Share of capital
- 14.4 % of 54.2M shares on Aug 3, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Fidelity Contrafund Fidelity Contrafund | 1,275,800 | 13.5M $ | 0.01 % | 2.36 % | as of Mar 31, 2026 ↗ |
| SMALLCAP World Fund Inc SMALLCAP World Fund Inc | 1,143,637 | 12.1M $ | 0.01 % | 2.11 % | as of Mar 31, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 722,389 | 10M $ | 0.15 % | 1.33 % | as of Feb 27, 2026 ↗ |
| T. Rowe Price Small-Cap Value Fund, Inc. T. ROWE PRICE SMALL-CAP VALUE FUND, INC. | 717,600 | 7.6M $ | 0.08 % | 1.32 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 711,917 | 7.5M $ | 0.00 % | 1.31 % | as of Mar 31, 2026 ↗ |
| AB Small Cap Growth Portfolio AB CAP FUND, INC. | 490,769 | 4.7M $ | 0.16 % | 0.91 % | as of Apr 30, 2026 ↗ |
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 436,200 | 6M $ | 0.01 % | 0.81 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 349,098 | 3.7M $ | 0.03 % | 0.64 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 331,160 | 3.5M $ | 0.03 % | 0.61 % | as of Mar 31, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 305,088 | 4.2M $ | 0.08 % | 0.56 % | as of Feb 28, 2026 ↗ |
| Fidelity Contrafund K6 Fidelity Contrafund | 268,874 | 2.8M $ | 0.01 % | 0.50 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 236,025 | 2.5M $ | 0.00 % | 0.44 % | as of Mar 31, 2026 ↗ |
| SmallCap Growth Fund I Principal Funds, Inc | 138,867 | 1.3M $ | 0.06 % | 0.26 % | as of Apr 30, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 127,376 | 1.2M $ | 0.12 % | 0.24 % | as of Apr 30, 2026 ↗ |
| BlackRock Event Driven Equity Fund BlackRock Large Cap Series Funds, Inc. | 124,234 | 1.7M $ | 0.03 % | 0.23 % | as of Feb 27, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 123,500 | 1.7M $ | 0.01 % | 0.23 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 111,500 | 1.5M $ | 0.01 % | 0.21 % | as of Feb 28, 2026 ↗ |
| Health Sciences Portfolio PACIFIC SELECT FUND | 43,100 | 456K $ | 0.13 % | 0.08 % | as of Mar 31, 2026 ↗ |
| AVIP AB Small Cap Portfolio AuguStar Variable Insurance Products Fund Inc | 24,352 | 257.6K $ | 0.09 % | 0.04 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 20,976 | 221.9K $ | 0.03 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 14,000 | 134.6K $ | 0.00 % | 0.03 % | as of Apr 30, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 11,999 | 126.9K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 2000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 11,872 | 163.6K $ | 0.00 % | 0.02 % | as of Feb 28, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 9,490 | 100.4K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| AB Small Cap Growth Portfolio AB VARIABLE PRODUCTS SERIES FUND, INC. | 8,626 | 91.3K $ | 0.19 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 7,211 | 76.3K $ | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 7,080 | 74.9K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Large-Cap Growth Portfolio PACIFIC SELECT FUND | 6,500 | 68.8K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Care ETF T. Rowe Price Exchange-Traded Funds, Inc. | 5,840 | 61.8K $ | 0.31 % | 0.01 % | as of Mar 31, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 5,071 | 53.7K $ | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| HARTFORD HEALTHCARE HLS FUND HARTFORD SERIES FUND INC | 2,100 | 22.2K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AVIP Fidelity Institutional AM Equity Growth Portfolio AuguStar Variable Insurance Products Fund Inc | 1,300 | 13.8K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares Health Innovation Active ETF BlackRock ETF Trust | 1,253 | 12K $ | 0.12 % | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD RUSSELL 2000 GROWTH INDEX FUND VANGUARD SCOTTSDALE FUNDS | 1,156 | 15.9K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Guardian Large Cap Fundamental Growth VIP Fund Guardian Variable Products Trust | 900 | 9.5K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 2000 VALUE INDEX FUND VANGUARD SCOTTSDALE FUNDS | 367 | 5.1K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD RUSSELL 3000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 218 | 3K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| T. Rowe Price Health Care ETF T. Rowe Price Exchange-Traded Funds, Inc. | 0.31 % | as of Mar 31, 2026 ↗ |
| AB Small Cap Growth Portfolio AB VARIABLE PRODUCTS SERIES FUND, INC. | 0.19 % | as of Mar 31, 2026 ↗ |
| AB Small Cap Growth Portfolio AB CAP FUND, INC. | 0.16 % | as of Apr 30, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 0.15 % | as of Feb 27, 2026 ↗ |
| Health Sciences Portfolio PACIFIC SELECT FUND | 0.13 % | as of Mar 31, 2026 ↗ |
| iShares Health Innovation Active ETF BlackRock ETF Trust | 0.12 % | as of Apr 30, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 0.12 % | as of Apr 30, 2026 ↗ |
| AVIP AB Small Cap Portfolio AuguStar Variable Insurance Products Fund Inc | 0.09 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Small-Cap Value Fund, Inc. T. ROWE PRICE SMALL-CAP VALUE FUND, INC. | 0.08 % | as of Mar 31, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 0.08 % | as of Feb 28, 2026 ↗ |
Institutional managers
48 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 3,836,830 | 40.6M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 3,319,379 | 35.1M $ | as of Mar 31, 2026 |
| Foresite Capital Management IV, LLC | 1,943,682 | 20.6M $ | as of Mar 31, 2026 |
| Merck & Co., Inc. | 1,666,666 | 17.6M $ | as of Mar 31, 2026 |
| Foresite Capital Management V, LLC | 1,318,983 | 14M $ | as of Mar 31, 2026 |
| T. Rowe Price Investment Management, Inc. | 1,222,487 | 12.9K $ | as of Mar 31, 2026 |
| Capital World Investors | 1,143,637 | 12.1M $ | as of Mar 31, 2026 |
| ALLIANCEBERNSTEIN L.P. | 1,022,188 | 10.8M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 975,834 | 10.3K $ | as of Mar 31, 2026 |
| EcoR1 Capital, LLC | 732,606 | 7.8M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 555,555 | 5.9M $ | as of Mar 31, 2026 |
| SOROS CAPITAL MANAGEMENT LLC | 484,672 | 5.1M $ | as of Mar 31, 2026 |
| StepStone Group LP | 395,340 | 4.2M $ | as of Mar 31, 2026 |
| CANADA PENSION PLAN INVESTMENT BOARD | 379,024 | 4M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 350,000 | 3.7M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 310,000 | 3.3M $ | as of Mar 31, 2026 |
| General Catalyst Group Management, LLC | 305,233 | 3.2M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 273,931 | 2.9M $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 265,000 | 2.8M $ | as of Mar 31, 2026 |
| Ensign Peak Advisors, Inc | 200,000 | 2.1M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 185,000 | 2M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 175,627 | 1.9M $ | as of Mar 31, 2026 |
| Blackstone Inc. | 168,338 | 1.8M $ | as of Mar 31, 2026 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 140,344 | 1.5M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 131,079 | 1.4M $ | as of Mar 31, 2026 |
Declared shareholders of Eikon Therapeutics Inc
4 beneficial ownership filings. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| FMR LLC and 1 other | 7.10 % | 3,836,830 | as of Mar 31, 2026 · SCHEDULE 13G |
| BlackRock Portfolio Management LLC | 5.50 % | 3,002,737 | as of Mar 31, 2026 · SCHEDULE 13G |
| PERLMUTTER ROGER M | 5.20 % | 2,893,171 | as of Feb 4, 2026 · SCHEDULE 13G |
| Innovation Endeavors III LP and 5 others | 5.00 % | 2,723,226 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Eikon Therapeutics Inc". https://titelia.com/en/stocks/eikon-therapeutics-inc-US2825641036